sangeetha palakurthi on fda approval of atezolizumab in nsclc
Published 7 years ago • 377 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc
-
1:37
sangeetha palakurthi on strategies for managing resistance to osimertinib in patients with nsclc
-
1:27
fda approval of atezolizumab for nsclc
-
7:05
the fda approval of atezolizumab in bladder cancer
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer
-
holy communion 1st service || 7th july 2024 || paralokanestham
-
24:33
dr.tapaswi krishna p about types of lung infections causes and treatment | gleneagles hospitals
-
4:41
parent's testimonial about recovered erb’s palsy - brachial plexus injury : sgs hospital, mysore-15
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
2:15
dr. wakelee on birch trial for atezolizumab in patients with nsclc
-
6:27
fda approval in nsclc, and ema regulatory advances in pancreatic cancer, nhl, and cll
-
1:28
dr. randy sweis on impact of atezolizumab approval in bladder cancer
-
4:48
gefitinib approved for nsclc, atezolizumab shrinks bladder tumors, and more
-
1:45
dr. chandra belani on atezolizumab in nsclc
-
1:33
dr. anne chiang on molecular testing in lung cancer treatment planning
-
1:07
dr. nanus on next steps with atezolizumab in patients with muc
-
0:53
ramalingam compares third generation egfr tki osimertinib to older agents in nsclc
-
1:21
dr. rosenberg on immunotherapeutic advances in bladder cancer
-
1:03
dr. pal on the sequencing of immunotherapy for urothelial carcinoma